3//SEC Filing
Mundipharma AG 3
Accession 0001567619-19-018258
CIK 0001610618other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:04 PM ET
Size
4.5 KB
Accession
0001567619-19-018258
Insider Transaction Report
Form 3
Mundipharma AG
10% Owner
Holdings
- 4,781,408
Common Stock, $0.0001 par value per share
Footnotes (1)
- [F1]Pursuant to the terms of that certain Stock Purchase Agreement, dated September 3, 2019 (the "Purchase Agreement"), by and between Cidara Therapeutics, Inc., a Delaware corporation (the "Company"), and Mundipharma AG, an entity with its principal place of business in Switzerland (the "Reporting Person"), the Reporting Person purchased from the Company 4,781,408 shares of the Company's common stock, $0.0001 par value per share, for an aggregate purchase price of approximately $9.0 million.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0001787709
Filing Metadata
- Form type
- 3
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:04 PM ET
- Size
- 4.5 KB